David C. Evans
Merck & Co Inc
Drug Metabolism
Rahway
NJ 07065
USA
Name/email consistency: high
- Minimizing the potential for metabolic activation as an integral part of drug design. Evans, D.C., Baillie, T.A. Curr. Opin. Drug. Discov. Devel (2005)
- Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development. Evans, D.C., Watt, A.P., Nicoll-Griffith, D.A., Baillie, T.A. Chem. Res. Toxicol. (2004)
- Eletriptan metabolism by human hepatic CYP450 enzymes and transport by human P-glycoprotein. Evans, D.C., O'Connor, D., Lake, B.G., Evers, R., Allen, C., Hargreaves, R. Drug Metab. Dispos. (2003)